The therapeutic use of fluroquinolones in poultry: the effect on Campylobacter and the potential human health consequences
Guest Editors: Otto Radostits and Ethan Rubinstein

3S1 Introduction

3S3 The health and management of poultry production
Charles L. Hofacre

3S8 Assessment of the National Antimicrobial Resistance Monitoring System (NARMS) and its value in critical decision-making
Michael E. Ginevan

3S16 The ecology of Campylobacter jejuni in the avian hosts and in the environment
Diane G. Newell

3S22 Genetic differentiation of Campylobacter
Trudy Wassenaar

3S26 Re-examining the causes of campylobacteriosis
Louis A. Cox

3S37 Impact and management of Campylobacter in human medicine-US perspective
Mark S. Pasternack

3S44 Impact and management of Campylobacter in human medicine-European perspective
Manfred Kist

3S49 The therapuetic use of fluoroquinolones in poultry: the efect on Campylobacter and the potential human health consequences
Otto Radostits and Ethan Rubinstein

3S53 Round-table discussion

*Publication of this supplement was aided by an unrestricted educational grant from Bayer Healthcare